Skip to main content
Erschienen in: World Journal of Surgery 2/2015

01.02.2015 | Original Scientific Report

1000 Port-A-Cath® Placements by Subclavian Vein Approach: Single Surgeon Experience

verfasst von: S. Mudan, A. Giakoustidis, D. Morrison, S. Iosifidou, R. Raobaikady, K. Neofytou, J. Stebbing

Erschienen in: World Journal of Surgery | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Totally implantable venous access ports are widely used for the administration of chemotherapy in patients with cancer. Although there are several approaches to implantation, here we describe Port-A-Cath® (PAC) placement by percutaneous puncture of the subclavian vein with ultrasonographic guidance.

Patients and methods

Data on our vascular access service were collected prospectively from June 2004. This service included port-a-caths and Hickman lines. Once 1000 consecutive port-a-caths® had been reached the study was closed and data analysed for the port-a-caths® alone. The left subclavian vein was the preferred site for venous access, with the right subclavian and jugular veins being the alternative choices if the initial approach failed. Patients were followed up in the short-term, and all the procedures were carried out by a single surgeon at each one of two institutions.

Results

Venous access by PAC was established in 100 % of the 1,000 cases. Of the 952 patients where the left subclavian vein was chosen for the first attempt of puncture, the success rate of PAC placement was 95 % (n = 904). Pneumothorax occurred in 12 patients (1.2 %), and a wound haematoma occurred in 4 (0.4 %) out of the total 1,000 patients. No infections were recorded during the immediate post-operative period but only in the long-term post-operative use with 8 patients requiring removal of the PAC due to infection following administration of chemotherapy.

Conclusion

This is a very large series of PAC placement with an ultrasound-guided approach for left subclavian vein and X-ray confirmation, performed by a single surgeon, demonstrating both the safety and effectiveness of the procedure.
Literatur
1.
Zurück zum Zitat Silberzweig JE, Sacks D, Khorsandi AS et al (2003) Reporting standards for central venous access. J Vasc Interv Radiol 14:443–452CrossRef Silberzweig JE, Sacks D, Khorsandi AS et al (2003) Reporting standards for central venous access. J Vasc Interv Radiol 14:443–452CrossRef
2.
Zurück zum Zitat Bow EJ, Kilpatrick MG, Clinch JJ (1999) Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: a randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life. J Clin Oncol 17:1267PubMed Bow EJ, Kilpatrick MG, Clinch JJ (1999) Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: a randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life. J Clin Oncol 17:1267PubMed
3.
Zurück zum Zitat Niederhuber JE, EnsmingerW Gyves JW et al (1982) Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 92:706–712PubMed Niederhuber JE, EnsmingerW Gyves JW et al (1982) Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 92:706–712PubMed
4.
Zurück zum Zitat Di Carlo I, Cordio S, La Greca G et al (2001) Totally implantable venous access devices implanted surgically: a retrospective study on early and late complications. Arch Surg 136:1050–1053PubMedCrossRef Di Carlo I, Cordio S, La Greca G et al (2001) Totally implantable venous access devices implanted surgically: a retrospective study on early and late complications. Arch Surg 136:1050–1053PubMedCrossRef
5.
Zurück zum Zitat Seiler CM, Frohlich BE, Dorsam UJ et al (2006) Surgical technique for totally implantable access ports (TIAP) needs improvement: a multivariate analysis of 400 patients. J Surg Oncol 93:24–29PubMedCrossRef Seiler CM, Frohlich BE, Dorsam UJ et al (2006) Surgical technique for totally implantable access ports (TIAP) needs improvement: a multivariate analysis of 400 patients. J Surg Oncol 93:24–29PubMedCrossRef
6.
Zurück zum Zitat Torramade JR, Cienfuegos JA, Hernandez JL et al (1993) The complications of central venous access systems: a study of 218 patients. Eur J Surg 159:323–327PubMed Torramade JR, Cienfuegos JA, Hernandez JL et al (1993) The complications of central venous access systems: a study of 218 patients. Eur J Surg 159:323–327PubMed
7.
Zurück zum Zitat Knebel P, Fischer L, Huesing J et al (2009) Randomized clinical trial of a modified Seldinger technique for open central venous cannulation for implantable access devices. Br J Surg 96:159–165PubMedCrossRef Knebel P, Fischer L, Huesing J et al (2009) Randomized clinical trial of a modified Seldinger technique for open central venous cannulation for implantable access devices. Br J Surg 96:159–165PubMedCrossRef
8.
Zurück zum Zitat Ignatov A, Hoffman O, Smith B et al (2009) An 11-year retrospective study of totally implanted central venous access ports: complications and patient satisfaction. Eur J Surg Oncol 35:241–246PubMedCrossRef Ignatov A, Hoffman O, Smith B et al (2009) An 11-year retrospective study of totally implanted central venous access ports: complications and patient satisfaction. Eur J Surg Oncol 35:241–246PubMedCrossRef
9.
Zurück zum Zitat Reeves AR, Shashadri R, Trerotola SO (2001) Recent trends in central venous catheter placement: a comparison of interventional radiology with other specialties. J Vasc Interv Radiol 12:1211–1214PubMedCrossRef Reeves AR, Shashadri R, Trerotola SO (2001) Recent trends in central venous catheter placement: a comparison of interventional radiology with other specialties. J Vasc Interv Radiol 12:1211–1214PubMedCrossRef
10.
Zurück zum Zitat Funaki B, Szymski GX, Hackworth CA et al (1997) Radiologic placement of subcutaneous infusion chest ports for longterm central venous access. AJR Am J Roentgenol 169:1431–1434PubMedCrossRef Funaki B, Szymski GX, Hackworth CA et al (1997) Radiologic placement of subcutaneous infusion chest ports for longterm central venous access. AJR Am J Roentgenol 169:1431–1434PubMedCrossRef
11.
Zurück zum Zitat LaBella G, Kerlakian G, Muck P et al (2005) Port-A-Cath placement without the aid of fluoroscopy or localizing devices: a community hospital series. Cancer J 11:157PubMedCrossRef LaBella G, Kerlakian G, Muck P et al (2005) Port-A-Cath placement without the aid of fluoroscopy or localizing devices: a community hospital series. Cancer J 11:157PubMedCrossRef
12.
Zurück zum Zitat Horng HC, Yuan CC, Chao KC et al (2007) A simple method to accurately position Port-A-Cath without the aid of intraoperative fluoroscopy or other localizing devices. J Surg Oncol 95:582PubMedCrossRef Horng HC, Yuan CC, Chao KC et al (2007) A simple method to accurately position Port-A-Cath without the aid of intraoperative fluoroscopy or other localizing devices. J Surg Oncol 95:582PubMedCrossRef
13.
Zurück zum Zitat National Institute for Clinical Excellence (2002) Guidance on the use of ultrasound locating devices for placing central venous catheters. NICE, London National Institute for Clinical Excellence (2002) Guidance on the use of ultrasound locating devices for placing central venous catheters. NICE, London
14.
15.
Zurück zum Zitat Ku YH, Kuo PH, Tsai YF et al (2009) Port-A-Cath implantation using percutaneous puncture without guidance. Ann Surg Oncol 16:729–734PubMedCrossRef Ku YH, Kuo PH, Tsai YF et al (2009) Port-A-Cath implantation using percutaneous puncture without guidance. Ann Surg Oncol 16:729–734PubMedCrossRef
16.
Zurück zum Zitat Biffi R, Corrado F, Braud F et al (1997) Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumors: experience from 178 cases using a single type of device. Eur J Cancer 33:1190–1194PubMedCrossRef Biffi R, Corrado F, Braud F et al (1997) Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumors: experience from 178 cases using a single type of device. Eur J Cancer 33:1190–1194PubMedCrossRef
17.
Zurück zum Zitat Charles HW, Miguel T, Kovacs S et al (2009) Chest port placement with use of the single-incision insertion technique. J Vasc Interv Radiol 20:1464–1469PubMedCrossRef Charles HW, Miguel T, Kovacs S et al (2009) Chest port placement with use of the single-incision insertion technique. J Vasc Interv Radiol 20:1464–1469PubMedCrossRef
18.
Zurück zum Zitat Lorch H, Zwaan M, Kagel C et al (2001) Central venous access ports placed by interventional radiologists: experience with 125 consecutive patients. Cardiovasc Intervent Radiol 24:180–184PubMedCrossRef Lorch H, Zwaan M, Kagel C et al (2001) Central venous access ports placed by interventional radiologists: experience with 125 consecutive patients. Cardiovasc Intervent Radiol 24:180–184PubMedCrossRef
19.
Zurück zum Zitat Yip D, Funaki B (2002) Subcutaneous chest ports via the internal jugular vein: a retrospective study of 117 oncology patients. Acta Radiol 43:371–375PubMedCrossRef Yip D, Funaki B (2002) Subcutaneous chest ports via the internal jugular vein: a retrospective study of 117 oncology patients. Acta Radiol 43:371–375PubMedCrossRef
20.
Zurück zum Zitat Nocito A, Wildi S, Rufibach K et al (2009) Randomized clinical trial comparing venous cutdown with the Seldinger technique for placement of implantable venous access ports. Br J Surg 96:1129–1134PubMedCrossRef Nocito A, Wildi S, Rufibach K et al (2009) Randomized clinical trial comparing venous cutdown with the Seldinger technique for placement of implantable venous access ports. Br J Surg 96:1129–1134PubMedCrossRef
21.
Zurück zum Zitat Ballarini C, Intra M, Pisani Ceretti A et al (1999) Complications of subcutaneous infusion port in the general oncology population. Oncology 56:97–102PubMedCrossRef Ballarini C, Intra M, Pisani Ceretti A et al (1999) Complications of subcutaneous infusion port in the general oncology population. Oncology 56:97–102PubMedCrossRef
22.
Zurück zum Zitat Shetty PC, Mody MK, Kastan DJ et al (1997) Outcome of 350 implanted chest ports placed by interventional radiologists. J Vasc Interv Radiol 8:991–995PubMedCrossRef Shetty PC, Mody MK, Kastan DJ et al (1997) Outcome of 350 implanted chest ports placed by interventional radiologists. J Vasc Interv Radiol 8:991–995PubMedCrossRef
23.
Zurück zum Zitat Davis SJ, Thompson JS, Edney JA (1984) Insertion of Hickman catheters. A comparison of cutdown and percutaneous techniques. Am Surg 50:673–676PubMed Davis SJ, Thompson JS, Edney JA (1984) Insertion of Hickman catheters. A comparison of cutdown and percutaneous techniques. Am Surg 50:673–676PubMed
24.
Zurück zum Zitat Teichgräber UK, Kausche S, Nagel SN et al (2011) Outcome analysis in 3,160 implantations of radiologically guided placements of totally implantable central venous port systems. Eur Radiol 21:1224–1232PubMedCrossRef Teichgräber UK, Kausche S, Nagel SN et al (2011) Outcome analysis in 3,160 implantations of radiologically guided placements of totally implantable central venous port systems. Eur Radiol 21:1224–1232PubMedCrossRef
25.
Zurück zum Zitat Caridi JG, Hawkins IF Jr, Wiechmann BN et al (1998) Sonographic guidance when using the right internal jugular vein for central vein access. AJR Am J Roentgenol 171:1259–1263PubMedCrossRef Caridi JG, Hawkins IF Jr, Wiechmann BN et al (1998) Sonographic guidance when using the right internal jugular vein for central vein access. AJR Am J Roentgenol 171:1259–1263PubMedCrossRef
26.
Zurück zum Zitat Groebli Y, Wutrich P, Safa M et al (1999) Utility and complications of permanent venous access devices (PVAD) in oncological treatments. Follow-up of 100 cases. Panminerva Med 41:89–92PubMed Groebli Y, Wutrich P, Safa M et al (1999) Utility and complications of permanent venous access devices (PVAD) in oncological treatments. Follow-up of 100 cases. Panminerva Med 41:89–92PubMed
27.
28.
Zurück zum Zitat Vandoni RE, Guerra A, Sanna P (2009) Randomised comparison of complications from three different permanent central venous access systems. Swiss Med Wkly 139:313–316PubMed Vandoni RE, Guerra A, Sanna P (2009) Randomised comparison of complications from three different permanent central venous access systems. Swiss Med Wkly 139:313–316PubMed
29.
Zurück zum Zitat Behrendt FF, Wingen M, Katoh M (2006) Evaluation of catheter loops in central venous port systems. Invest Radiol 41:777–780PubMedCrossRef Behrendt FF, Wingen M, Katoh M (2006) Evaluation of catheter loops in central venous port systems. Invest Radiol 41:777–780PubMedCrossRef
30.
Zurück zum Zitat Ahn SJ, Kim HC, Chung HW, An SB, Yin YH, Jae HJ, Park HJ (2012) Ultrasound and fluoroscopy-guided placement of central venous ports via internal jugular vein: retrospective analysis of 1254 port implantations at a single center. Korean J Radiol 13(3):314–323PubMedCentralPubMedCrossRef Ahn SJ, Kim HC, Chung HW, An SB, Yin YH, Jae HJ, Park HJ (2012) Ultrasound and fluoroscopy-guided placement of central venous ports via internal jugular vein: retrospective analysis of 1254 port implantations at a single center. Korean J Radiol 13(3):314–323PubMedCentralPubMedCrossRef
31.
Zurück zum Zitat Sugimoto T, Nagata H, Hayashi K (2012) Pinch-off syndrome: transection of implantable central venous access device. BMJ Case Rep bcr2012006584. doi: 10.1136/bcr-2012-006584 Sugimoto T, Nagata H, Hayashi K (2012) Pinch-off syndrome: transection of implantable central venous access device. BMJ Case Rep bcr2012006584. doi: 10.​1136/​bcr-2012-006584
32.
Zurück zum Zitat Paleczny J, Banyś-Jafernik B, Gazurek K et al (2013) Long-term totally implantable venous access port systems—one center experience. Anaesthesiol Intensive Ther 45:215–222PubMedCrossRef Paleczny J, Banyś-Jafernik B, Gazurek K et al (2013) Long-term totally implantable venous access port systems—one center experience. Anaesthesiol Intensive Ther 45:215–222PubMedCrossRef
33.
Zurück zum Zitat Keung YK, Watkins K, Chen SC et al (1995) Increased incidence of central venous catheter-related infections in bone marrow transplant patients. Am J Clin Oncol 18:469–474PubMedCrossRef Keung YK, Watkins K, Chen SC et al (1995) Increased incidence of central venous catheter-related infections in bone marrow transplant patients. Am J Clin Oncol 18:469–474PubMedCrossRef
34.
Zurück zum Zitat Greene FL, Moore W, Gb Strikland (1988) Comparison of a totally implantable access device for chemotherapy (Port-A-Cath) and long-term percutaneous catheterization (Broviac). South Med J 81:580–583PubMedCrossRef Greene FL, Moore W, Gb Strikland (1988) Comparison of a totally implantable access device for chemotherapy (Port-A-Cath) and long-term percutaneous catheterization (Broviac). South Med J 81:580–583PubMedCrossRef
35.
Zurück zum Zitat Mueller BU, Skelton J, Callender DPE et al (1992) A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 10:1943–1948PubMed Mueller BU, Skelton J, Callender DPE et al (1992) A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 10:1943–1948PubMed
36.
Zurück zum Zitat Biffi R, Pozzi S, Agazzi A (2004) Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients. Ann Oncol 15:296–300PubMedCrossRef Biffi R, Pozzi S, Agazzi A (2004) Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients. Ann Oncol 15:296–300PubMedCrossRef
37.
Zurück zum Zitat Morrison VA, Peterson BA et al (1990) Nosocomial septicemia in the cancer patient: the influence of central venous access devices, neutropenia and type of malignancy. Med Pediatr Oncol 18:209–216PubMedCrossRef Morrison VA, Peterson BA et al (1990) Nosocomial septicemia in the cancer patient: the influence of central venous access devices, neutropenia and type of malignancy. Med Pediatr Oncol 18:209–216PubMedCrossRef
38.
Zurück zum Zitat Groeger Lucas AB, Thaler HT et al (1993) Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 119:1168–1174CrossRef Groeger Lucas AB, Thaler HT et al (1993) Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 119:1168–1174CrossRef
39.
Zurück zum Zitat Simon C, Suttorp M (1994) Results of antibiotic treatment of Hickman-catheter-related infections in oncological patients. Support Care Cancer 2:66–70PubMedCrossRef Simon C, Suttorp M (1994) Results of antibiotic treatment of Hickman-catheter-related infections in oncological patients. Support Care Cancer 2:66–70PubMedCrossRef
40.
Zurück zum Zitat Pasquale MD, Campbell JM, Magnant CM (1992) Groshong versus Hickman catheters. Surg Gynecol Obstet 174:408–410PubMed Pasquale MD, Campbell JM, Magnant CM (1992) Groshong versus Hickman catheters. Surg Gynecol Obstet 174:408–410PubMed
41.
Zurück zum Zitat Cil BE, Canyigit M, Peynircioglu B et al (2006) Subcutaneous venous port implantation in adult patients: a single center experience. Diagn Interv Radiol 12:93–98PubMed Cil BE, Canyigit M, Peynircioglu B et al (2006) Subcutaneous venous port implantation in adult patients: a single center experience. Diagn Interv Radiol 12:93–98PubMed
42.
Zurück zum Zitat Scordamaglia RE, Romairone S, Scabini E et al (2012) Totally implantable central venous access devices: results of a mono-centre series of 1610 port implantations performed under ultrasound and fluoroscopic guidance. Eur Surg 44(2):116–119. doi:10.1007/s10353-011-0046-7 CrossRef Scordamaglia RE, Romairone S, Scabini E et al (2012) Totally implantable central venous access devices: results of a mono-centre series of 1610 port implantations performed under ultrasound and fluoroscopic guidance. Eur Surg 44(2):116–119. doi:10.​1007/​s10353-011-0046-7 CrossRef
43.
Zurück zum Zitat Lebeaux D, Fernández-Hidalgo N, Chauhan A et al (2014) Management of infections related to totally implantable venous-access ports: challenges and perspectives. Lancet Infect Dis 14:146–159PubMedCrossRef Lebeaux D, Fernández-Hidalgo N, Chauhan A et al (2014) Management of infections related to totally implantable venous-access ports: challenges and perspectives. Lancet Infect Dis 14:146–159PubMedCrossRef
44.
Zurück zum Zitat Taxbro K, Berg S, Hammarskjöld F et al (2013) A prospective observational study on 249 subcutaneous central vein access ports in a Swedish county hospital. Acta Oncol 52:893–901PubMedCrossRef Taxbro K, Berg S, Hammarskjöld F et al (2013) A prospective observational study on 249 subcutaneous central vein access ports in a Swedish county hospital. Acta Oncol 52:893–901PubMedCrossRef
45.
Zurück zum Zitat Shaw JH, Douglas R, Wilson T (1988) Clinical performance of Hickman and Portacath atrial catheters. Aust N Z J Surg 58:657–659PubMedCrossRef Shaw JH, Douglas R, Wilson T (1988) Clinical performance of Hickman and Portacath atrial catheters. Aust N Z J Surg 58:657–659PubMedCrossRef
46.
Zurück zum Zitat Biffi R, de Braud F, Orsi F et al (1998) Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol 9:767–773PubMedCrossRef Biffi R, de Braud F, Orsi F et al (1998) Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol 9:767–773PubMedCrossRef
47.
Zurück zum Zitat Eastridge BJ, Lefor AT (1995) Complications of indwelling venous access devices in cancer patients. J Clin Oncol 13:233–238PubMed Eastridge BJ, Lefor AT (1995) Complications of indwelling venous access devices in cancer patients. J Clin Oncol 13:233–238PubMed
48.
Zurück zum Zitat Tonkin JL, Campbell G, Golding L et al (2008) Atrial thrombosis: a near fatal complication of a Portacath. J Vasc Access 9:148–151PubMed Tonkin JL, Campbell G, Golding L et al (2008) Atrial thrombosis: a near fatal complication of a Portacath. J Vasc Access 9:148–151PubMed
Metadaten
Titel
1000 Port-A-Cath® Placements by Subclavian Vein Approach: Single Surgeon Experience
verfasst von
S. Mudan
A. Giakoustidis
D. Morrison
S. Iosifidou
R. Raobaikady
K. Neofytou
J. Stebbing
Publikationsdatum
01.02.2015
Verlag
Springer US
Erschienen in
World Journal of Surgery / Ausgabe 2/2015
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-014-2802-x

Weitere Artikel der Ausgabe 2/2015

World Journal of Surgery 2/2015 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.